Advantages of CyberKnife for inoperable stage I peripheral non-small-cell lung cancer compared to three-dimensional conformal radiotherapy

Tong,An‑Na; Yan,Peng; Yuan,Guang‑Hui; Lv,Xiao‑Yan; Gong,Hai; Zhao,Hui; Wang,Yan‑Ming

doi:10.3892/mco.2014.475

Advantages of CyberKnife for inoperable stage I peripheral non-small-cell lung cancer compared to three-dimensional conformal radiotherapy

Authors:
- An‑Na Tong
- Peng Yan
- Guang‑Hui Yuan
- Xiao‑Yan Lv
- Hai Gong
- Hui Zhao
- Yan‑Ming Wang
View Affiliations

Affiliations: Department of Radiation Oncology, Jinan Military General Hospital, Jinan, Shandong 250031, P.R. China, Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China
Published online on: December 10, 2014 https://doi.org/10.3892/mco.2014.475
Pages: 442-448

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study was conducted to compare the clinical curative effect and acute radiation lung reactions between CyberKnife (CK) and three‑dimensional conformal radiotherapy (3DCRT) treatment for inoperable stage I peripheral non‑small‑cell lung cancer (NSCLC). We retrospectively analyzed 68 patients with inoperable stage I peripheral NSCLC between 2012 and 2013 in our institution. The CK patients were treated with 42‑60 Gy in three fractions, while the 3DCRT patients were treated with a total of 60 Gy, at 2 Gy per fraction. The patients were followed up and the clinical outcome was evaluated according to the Response Evaluation Criteria in Solid Tumours. We assessed the presence of acute radiation pneumonitis and pulmonary function status by thoracic scan and pulmonary function tests following CK and 3DCRT treatment. The binary univariate logistic regression analysis demonstrated that treatment method and forced expiratory volume in 1 sec̸forced vital capacity (FEV1̸FVC) prior to treatment (pre‑FEV1̸FVC) were the main factors affecting the risk of radiation pneumonitis. The analysis of these factors through multivariate logistic regression method demonstrated that treatment method for grade 1 and 2 [odds ratio (OR)=7.866 and 11.334, respectively) and pre‑FEV1/FVC for grade 1, 2 and 3 (OR=5.062, 11.498 and 15.042, respectively) were significant factors affecting the risk of radiation pneumonitis (P<0.05). the 68 patients were divided into two subgroups using the threshold of pre‑FEV1/FVC selected by the receiver operating characteristic curve. There were significant differences between the 3DCRT and CK treatment in both the pre‑FEV1̸FVC <68% and ≥68% subgroups for radiation pneumonitis (P=0.023 and 0.002, respectively). There was no statistically significant change in FVC, FEV1 and carbon monoxide diffusion capacity (DCLO) in the CK group, whereas there was a decrease in DCLO in the 3DCRT group. The complete remission rate was 40 vs. 34.2% at 1 year in the CK and 3DCRT groups, respectively. In conclusion, in this cohort of patients with inoperable stage I peripheral NSCLC, CK appears to be a safe and superior alternative to conventionally fractionated radiotherapy.

View Figures

View References

1	Qiao X, Tullgren O, Lax I, et al: The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer. 41:1–11. 2003. View Article : Google Scholar : PubMed/NCBI
2	Rodrigues G, Lock M, D'Souza D, et al: Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer - a systematic review. Radiother Oncol. 71:127–138. 2004. View Article : Google Scholar : PubMed/NCBI
3	Brown WT, Wu X, Fayad F, et al: Cyber Knife radiosurgery for stage I lung cancer: results at 36 months. Clin Lung Cancer. 8:488–492. 2007. View Article : Google Scholar : PubMed/NCBI
4	van der Voort van Zyp NC, Prévost JB, Hoogeman MS, et al: Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome. Radiother Oncol. 91:296–300. 2009. View Article : Google Scholar : PubMed/NCBI
5	Timmerman R, Paulus R, Galvin J, et al: Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 303:1070–1076. 2010. View Article : Google Scholar : PubMed/NCBI
6	Collins BT, Vahdat S, Erickson K, et al: Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer. J Hematol Oncol. 2:12009. View Article : Google Scholar : PubMed/NCBI
7	Banovac F, McRae D, Dieterich S, et al: Percutaneous placement of fiducial markers for thoracic malignancies. Robotic Radiosurgery: Treating Tumors that Move with Respiration. Urschel HC, Kresel JJ, Luketich JD, Papiez L and Timmerman RD: Springer-Verlag; Berlin: pp. 15–29. 2007
8	Yousefi S, Collins BT, Reichner CA, et al: Complications of thoracic computed tomography-guided fiducial placement for the purpose of stereotactic body radiation therapy. Clin Lung Cancer. 8:252–256. 2007. View Article : Google Scholar : PubMed/NCBI
9	Radiation Therary Oncology Group, . Acute radiation morbidity scoring criteria. http://www.rtog.org/ResearchAssociates/AdverseEventReporting/AcuteRadiationMorbidityScoringCriteria.aspxAccessed. May 1–2012
10	Radiation Therapy Oncology Group/European Organization for Research Treatment of Cancer, . Late radiation morbidity scoring schema. Available at. http://www.rtog.org/ResearchAssociates/AdverseEventReporting/RTOGEORTCLateRadiationMorbidityScoringSchema.aspxAccessed. May 1–2012.
11	Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 92:205–216. 2000. View Article : Google Scholar : PubMed/NCBI
12	Vahdat S, Oermann EK, Collins SP, et al: Cyber Knife radiosurgery for inoperable stage IA non-small cell lung cancer:18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment. J Hematol Oncol. 3:62010. View Article : Google Scholar : PubMed/NCBI
13	Collins BT, Erickson K, Reichner CA, et al: Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Radiat Oncol. 2:392007. View Article : Google Scholar : PubMed/NCBI
14	Mehta M, Scrimger R, Mackie R, et al: A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 49:23–33. 2001. View Article : Google Scholar : PubMed/NCBI
15	Robnett TJ, Machtay M, Vines EF, et al: Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys. 48:89–94. 2000. View Article : Google Scholar : PubMed/NCBI
16	Kocak Z, Borst GR, Zeng J, et al: Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis. Int J Radiat Oncol Biol Phys. 67:178–186. 2007. View Article : Google Scholar : PubMed/NCBI
17	Lind PA, Marks LB, Hollis D, et al: Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys. 54:340–347. 2002. View Article : Google Scholar : PubMed/NCBI
18	Marks LB, Bentzen SM, Deasy JO, et al: Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys. 76 (Suppl 3):S70–S76. 2010. View Article : Google Scholar : PubMed/NCBI
19	Lopez Guerra JL, Gomez D, Zhuang Y, et al: Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 83:1573–1579. 2012. View Article : Google Scholar : PubMed/NCBI
20	Prevost JB, Voet P, Hoogeman M, et al: Four-dimensional stereotactic radiotherapy for early stage non-small cell lung cancer: a comparative planning study. Technol Cancer Res Treat. 7:27–33. 2008. View Article : Google Scholar : PubMed/NCBI
21	Gouders D, Maingon P, Paesmans M, et al: Exclusive radiotherapy for non-small cell lung cancer. A retrospective multicentric study. Rep Pract Oncol Radiother (Polish Soc Rad Oncol). 8:7–14. 2003. View Article : Google Scholar
22	Sibley GS, Jamieson TA, Marks LB, et al: Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys. 40:149–154. 1998. View Article : Google Scholar : PubMed/NCBI
23	Chen VJ, Oermann E, Vahdat S, et al: Cyber Knife with tumor tracking: an effective treatment for high-risk surgical patients with stage I non-small cell lung cancer. Front Oncol. 2:92012. View Article : Google Scholar : PubMed/NCBI